Loading...
XHKG1515
Market cap645mUSD
Jan 08, Last price  
3.90HKD
1D
-2.01%
1Q
-8.45%
Jan 2017
-60.69%
IPO
-66.03%
Name

China Resources Medical Holdings Company Ltd

Chart & Performance

D1W1MN
XHKG:1515 chart
P/E
18.37
P/S
0.47
EPS
0.20
Div Yield, %
0.84%
Shrs. gr., 5y
-0.05%
Rev. gr., 5y
37.46%
Revenues
10.11b
+79.83%
758,032,000887,354,0001,206,265,0001,372,267,0001,532,831,0001,877,724,0002,059,478,0002,115,320,0002,750,650,0004,447,477,0005,620,461,00010,107,500,000
Net income
258m
+85.42%
101,088,00089,992,000230,051,000167,045,000-1,506,964,000421,034,000430,898,000390,865,000310,131,000417,915,000138,974,000257,680,000
CFO
1.20b
+90.74%
166,419,000169,676,000274,213,000231,702,000223,788,000459,540,000334,146,000366,052,000643,688,000710,430,000626,583,0001,195,123,000
Dividend
Sep 09, 20240.0547 HKD/sh
Earnings
Mar 17, 2025

Profile

China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, and hospital management and consulting services in the People's Republic of China. The ocmapny operates in three segments: Self-Owned Hospitals, Invest-Operate-Transfer/Operate-Transfer Hospitals, and Others. It also offers group purchasing organization and other hospital-derived services. In addition, the company manages and operates third-party hospitals and clinics under the invest-operate-transfer model. Further, it sells pharmaceuticals, medical devices, and medical consumables and equipment. The company was formerly known as China Resources Phoenix Healthcare Holdings Company Limited and changed its name to China Resources Medical Holdings Company Limited in October 2018. China Resources Medical Holdings Company Limited was founded in 2007 and is headquartered in Beijing, the People's Republic of China.
URL
http://www.crmedical.hk/
IPO date
Nov 29, 2013
Employees
20,189
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
10,107,500
79.83%
5,620,461
26.37%
Cost of revenue
9,175,160
5,293,477
Unusual Expense (Income)
NOPBT
932,340
326,984
NOPBT Margin
9.22%
5.82%
Operating Taxes
165,031
83,071
Tax Rate
17.70%
25.41%
NOPAT
767,309
243,913
Net income
257,680
85.42%
138,974
-66.75%
Dividends
(42,353)
(129,601)
Dividend yield
0.70%
1.78%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,322,902
1,349,154
Long-term debt
1,137,158
1,081,460
Deferred revenue
41,449
Other long-term liabilities
445,265
(112,765)
Net debt
148,244
(2,443,873)
Cash flow
Cash from operating activities
1,195,123
626,583
CAPEX
(486,681)
(252,867)
Cash from investing activities
(2,622,095)
57,342
Cash from financing activities
(437,083)
(33,167)
FCF
(1,972,680)
71,422
Balance
Cash
1,280,382
3,301,844
Long term investments
1,031,434
1,572,643
Excess cash
1,806,441
4,593,464
Stockholders' equity
1,647,426
1,946,171
Invested Capital
8,122,295
14,223,131
ROIC
6.87%
2.31%
ROCE
9.54%
3.43%
EV
Common stock shares outstanding
1,264,292
1,262,019
Price
4.82
-16.32%
5.76
24.14%
Market cap
6,093,887
-16.17%
7,269,229
23.97%
EV
7,443,136
5,717,631
EBITDA
1,543,203
659,467
EV/EBITDA
4.82
8.67
Interest
114,862
46,231
Interest/NOPBT
12.32%
14.14%